Fingerprint
Dive into the research topics where Jeroen Janssen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study
Rubio-Alarcón, C., Georgiadis, A., Franken, I. A., Wang, H., van Nassau, S. C. M. W., Schraa, S. J., van der Kruijssen, D. E. W., van Rooijen, K., Linders, T. C., Delis-van Diemen, P., Alkemade, M., Bolijn, A., Tijssen, M., Lemmens, M., Meiqari, L., Ketelaars, S. L. C., Closa-Mosquera, A., van Dongen, M. M. W., Lanfermeijer, M. & Lissenberg-Witte, B. I. & 53 others, , 1 Jan 2026, In: British journal of surgery. 113, 1, znaf281.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile7 Downloads (Pure) -
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
Apperley, J. F., Milojkovic, D., Cross, N. C. P., Hjorth-Hansen, H., Hochhaus, A., Kantarjian, H., Lipton, J. H., Malhotra, H., Niederwieser, D., Radich, J., Rousselot, P., Saussele, S., Schiffer, C. A., Silver, R., Soverini, S., Stenke, L., Turkina, A., Casado, L. F., Castagnetti, F. & Cervantes, F. & 18 others, , Aug 2025, In: Leukemia. 39, 8, p. 1797-1813 17 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile13 Downloads (Pure) -
Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results
Cortes, J. E., Lang, F., Rea, D., Hochhaus, A., Breccia, M., Goh, Y. T., Heinrich, M. C., Hughes, T. P., Janssen, J. J. W. M., le Coutre, P., Minami, H., Sasaki, K., DeAngelo, D. J., Sanchez-Olle, G., Pognan, N., Cao, M., Hoch, M. & Mauro, M. J., May 2025, In: Leukemia. 39, 5, p. 1124-1134 11 p., 106458.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile15 Downloads (Pure) -
Benefits and Limitations of Real-World Patient-Reported Toxicity Symptom Monitoring for Guidelines and Care, as Perceived by Patients, Clinicians, and Guideline Developers
Smit, Y., Verweij, L., Currie, A., Janssen, J. J. W. M., Posthuma, E. F. M., Dekker, A., Hermens, R. P. M. G. & Blijlevens, N. M. A., 1 Apr 2025, In: Cancer medicine. 14, 8, e70880.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile22 Downloads (Pure) -
Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients
Hermans, S. J. F., Versluis, J., van Werkhoven, E. D., van Norden, Y., Janssen, J. J. W. M., Huls, G. A., Pabst, T., Breems, D. A., Berkx, E., Dinmohamed, A. G., Huijgens, P. C., Sträng, E., Hernández Rivas, J. M., Sobas, M., Ayala Diaz, R., Martinez Lopez, J., Metzeler, K. H., Haferlach, T., Thiede, C. & Uyl-de Groot, C. A. & 5 others, , 2025, (E-pub ahead of print) In: British journal of haematology.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile7 Downloads (Pure)